| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0001 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 5e-05 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 4e-05 | 1 |